There is increased risk for major gastrointestinal bleeding with edoxaban vs VKA therapy in patients with atrial fibrillation following TAVR.

The global transcatheter heart valve replacement (TAVR) market is estimated to be valued at USD 8.18 billion in 2025 and is projected to reach USD 32.82 billion by 2035, registering a compound annual ...

At Sanford Health in Bismarck, doctors have now performed 500 transcatheter aortic valve replacements, known as TAVR.

Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify patients for other approaches.

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the ...

Abstract Background Valve‐in‐valve transcatheter aortic valve replacement (TAVR) is a recognized alternative for treating the structural valve deterioration of bioprosthetic valves. Recent guidelines ...

In that surgery, called transcatheter aortic valve replacement, or TAVR, cardiologists insert a replacement valve through a patient’s groin and thread it all the way to the heart.

WASHINGTON — Among patients with asymptomatic severe aortic stenosis and myocardial fibrosis, transcatheter or surgical aortic valve replacement did not improve outcomes compared with ...